Skip to main content
. 2011 Jun 10;88(6):805–813. doi: 10.1016/j.ajhg.2011.04.022

Table 2.

Association between Phenotype of High Myopia and Genetic Variants at 13q12.12 in the Han Chinese populations

SNP Position Risk Allele Dataseta Number (Control/Case) RAFb(Control/Case) p_HWE (Control/Case) p Valuec Odds ratio (95% CI)d
Homozygote Heterozygote
rs9510902
23328312
A
GWAS (SH) 0/419 0/0.520 0/0.344 NA NA NA
FD1(WZ) 2525/843 0.452/0.512 0.723/0.419 1.92 × 10−5 1.62 (1.29, 2.02) 1.36 (1.13, 1.65)
FD2(CD) 1890/549 0.454/0.520 0.455/0.546 1.06 × 10−4 1.71 (1.31, 2.23) 1.20 (0.95, 1.52)
FD3(GD-HK) 1227/1411 0.464/0.510 0.515/0.643 8.26 × 10−4 1.44 (1.16, 1.78) 1.21 (1.01, 1.46)
Combined 5642/3222 0.455/0.514 0.908/0.627 6.32 × 10−14 1.60 (1.41, 1.80) 1.25 (1.12, 1.38)

rs9318086
23330467
A
GWAS (SH) 669/419 0.447/0.514 0.249/0.504 8.14 × 10−5 1.68 (1.19, 2.36) 1.33 (0.99, 1.78)
FD1(WZ) 2525/843 0.433/0.499 0.256/0.654 2.28 × 10−6 1.68 (1.35, 2.10) 1.40 (1.16, 1.69)
FD2(CD) 1890/549 0.435/0.513 0.963/0.532 5.09 × 10−6 1.86 (1.43, 2.44) 1.30 (1.03, 1.63)
FD3(GD-HK) 1227/1411 0.453/0.495 0.640/0.955 0.00217 1.40 (1.12, 1.74) 1.22 (1.02, 1.46)
Combined 6311/3222 0.439/0.502 0.178/0.806 1.91 × 10−16 1.64 (1.46, 1.85) 1.32 (1.19, 1.46)

rs3794338
23331291
T
GWAS (SH) 0/419 0/0.419 0/0.176 NA NA NA
FD1(WZ) 2525/843 0.348/0.389 0.319/0.133 0.00227 1.45 (1.15, 1.84) 1.13 (0.95, 1.34)
FD2(CD) 1890/549 0.348/0.418 0.593/0.852 2.10 × 10−5 1.79 (1.35, 2.39) 1.35 (1.10, 1.67)
FD3(GD-HK) 1227/1411 0.363/0.395 0.288/0.066 0.0152 1.33 (1.05, 1.67) 1.11 (0.94, 1.31)
Combined 5642/3222 0.351/0.401 0.137/0.010 5.46 × 10−11 1.54 (1.35, 1.76) 1.18 (1.07, 1.30)

rs1886970
23338498
G
GWAS (SH) 669/419 0.451/0.514 0.339/0.504 1.05 × 10−4 1.64 (1.16, 2.30) 1.29 (0.96, 1.73)
FD1(WZ) 2525/843 0.440/0.501 0.806/0.469 1.33 × 10−5 1.63 (1.30, 2.04) 1.35 (1.12, 1.64)
FD2(CD) 1890/549 0.438/0.512 0.766/0.711 1.67 × 10−5 1.81 (1.38, 2.37) 1.28 (1.02, 1.62)
FD3(GD-HK) 1227/1411 0.457/0.495 0.733/0.960 0.00512 1.36 (1.09, 1.69) 1.19 (0.99, 1.42)
Combined 6311/3222 0.444/0.502 0.636/0.945 2.31 × 10−14 1.59 (1.41, 1.80) 1.27 (1.15, 1.41)

rs7325450
23365004
G
GWAS (SH) 0/419 0/0.504 0/0.558 NA NA NA
FD1(WZ) 2525/843 0.436/0.493 0.598/0.254 4.31 × 10−5 1.59 (1.27, 1.99) 1.34 (1.11, 1.61)
FD2(CD) 1890/549 0.427/0.492 0.767/0.373 1.32 × 10−4 1.70 (1.30, 2.22) 1.19 (0.95, 1.49)
FD3(GD-HK) 1227/1411 0.450/0.491 0.969/0.640 0.00274 1.39 (1.12, 1.73) 1.15 (0.96, 1.38)
Combined 5642/3222 0.436/0.493 0.603/0.758 1.49 × 10−13 1.59 (1.41, 1.80) 1.23 (1.11, 1.36)

rs7331047 23365342 C GWAS (SH) 0/419 0/0.499 0/0.696 NA NA NA
FD1(WZ) 2525/843 0.425/0.486 0.769/0.589 1.42 × 10−5 1.62 (1.30, 2.03) 1.34 (1.11, 1.61)
FD2(CD) 1890/549 0.425/0.505 0.655/0.767 2.05 × 10−6 1.93 (1.47, 2.53) 1.33 (1.05, 1.67)
FD3(GD-HK) 1227/1411 0.449/0.491 0.857/0.531 0.00245 1.40 (1.12, 1.74) 1.16 (0.96, 1.38)
Combined 5642/3222 0.430/0.493 0.957/0.680 6.16 × 10−16 1.66 (1.47, 1.88) 1.27 (1.15, 1.41)
a

GWAS cohort: Shanghai cohort. FD1: follow-up dataset 1, Wenzhou cohort. FD2, follow-up dataset 2, Chengdu cohort. FD3, follow-up dataset 3, Guangdong-Hong Kong cohort.

b

RAF, frequency of risk allele.

c

The allelic p value was corrected by age and gender, and genomic control was used for the GWAS cohort.

d

CI: confidence interval.